Quantum Leap Healthcare Collaborative is a 501(c)(3) nonprofit clinical research and patient advocacy organization. We exist to accelerate the discovery, testing, and delivery of better treatments — so the right patient, gets the right treatment, at the right time. Patient Advocates participate in every aspect of our work in order to ensure diverse access and benefit from all our programs.
Every decision we make is rooted in one belief: research should move faster, learn continuously, and stay centered on the people it is meant to serve. As a vertically integrated trial sponsor, we design and run our own trials, manage contracting and regulatory affairs, and support investigators across our national network — bridging the gap between discovery and care.
Through our ACCESS program, we are committed to ensuring that clinical trials reflect the full diversity of the patients they are meant to help.
Our portfolio spans platform clinical trials testing new drugs in breast cancer(I-SPY 2, DCIS RECAST, and PRE-I-SPY), metastatic solid tumors including breast, colorectal, and GI cancers, and critical illness (I-SPY ARDS) — all united by a shared commitment to transforming patient insight and real-world collaboration into better outcomes for all.
Our values — integrity, collaboration, transparency, innovation, and equity — guide how we build trials, grow partnerships, and shape the future of patient-centric research.
Traditional drug development is slow, expensive, and tests one treatment at a time — leaving too many patients waiting too long for better options.
The answer was adaptive platform trials: a model that tests multiple treatments simultaneously, learns continuously from patient response data.
QLHC runs the trials end-to-end — from protocol development, regulatory approval, and patient treatment. The vertically integrated model keeps the focus on getting better treatments to patients sooner.
For media questions, speaking opportunities, or press-related requests, connect with our communications team.
Breakthroughs do not happen in isolation. They happen because diverse teams of researchers, strategists, clinicians, operators, and patient advocates come together around a shared mission. At QLHC, you'll work alongside people committed to moving better care forward faster — and building the future of patient-centric research.
Your support helps accelerate adaptive research, expand access to clinical trials, and bring breakthrough
models of care to more communities.
.png)
